US Patent Issued to Genentech on June 2 for "Apolipoprotein L1-specific antibodies and methods of use" (California Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,945, issued on June 2, was assigned to Genentech Inc. (South San Francisco, Calif.).

"Apolipoprotein L1-specific antibodies and methods of use" was invented by Suzanna Jane Scales (South San Francisco, Calif.), Nidhi Gupta (Redwood City, Calif.) and Andrew Scott Peterson (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides anti-apolipoprotein L1 (APOL1) antibodies, including anti-APOL1 antibodies that distinguish the G0 and G1 forms from the G2 form of APOL1, distinguish APOL1 found on podocytes from that found on HDL particles in serum, and distinguish APOL1 from apolipoproteins L2, L3, L4 and L6 (APOL2, APOL3, APOL...